FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078709072> ?p ?o ?g. }

• W2078709072 endingPage "e536" @default.
• W2078709072 startingPage "e531" @default.
• W2078709072 abstract "To investigate whether high-dose thoracic radiation given twice daily during cisplatin-etoposide chemotherapy for limited small-cell lung cancer (LSCLC) improves survival, acute esophagitis, and local control rates relative to findings from Intergroup trial 0096 (47%, 27%, and 64%).Patients were accrued over a 3-year period from 22 US and Canadian institutions. Patients with LSCLC and good performance status were given thoracic radiation to 61.2 Gy over 5 weeks (daily 1.8-Gy fractions on days 1-22, then twice-daily 1.8-Gy fractions on days 23-33). Cisplatin (60 mg/m(2) IV) was given on day 1 and etoposide (120 mg/m(2) IV) on days 1-3 and days 22-24, followed by 2 cycles of cisplatin plus etoposide alone. Patients who achieved complete response were offered prophylactic cranial irradiation. Endpoints included overall and progression-free survival; severe esophagitis (Common Toxicity Criteria v 2.0) and treatment-related fatalities; response (Response Evaluation Criteria in Solid Tumors); and local control.Seventy-two patients were accrued from June 2003 through May 2006; 71 were evaluable (median age 63 years; 52% female; 58% Zubrod 0). Median survival time was 19 months; at 2 years, the overall survival rate was 36.6% (95% confidence interval [CI] 25.6%-47.7%), and progression-free survival 19.7% (95% CI 11.4%-29.6%). Thirteen patients (18%) experienced severe acute esophagitis, and 2 (3%) died of treatment-related causes; 41% achieved complete response, 39% partial response, 10% stable disease, and 6% progressive disease. The local control rate was 73%. Forty-three patients (61%) received prophylactic cranial irradiation.The overall survival rate did not reach the projected goal; however, rates of esophagitis were lower, and local control higher, than projected. This treatment strategy is now one of three arms of a prospective trial of chemoradiation for LSCLC (Radiation Therapy Oncology Group 0538/Cancer and Leukemia Group B 30610)." @default.
• W2078709072 created "2016-06-24" @default.
• W2078709072 creator A5011307937 @default.
• W2078709072 creator A5019357584 @default.
• W2078709072 creator A5026088869 @default.
• W2078709072 creator A5032192226 @default.
• W2078709072 creator A5060222943 @default.
• W2078709072 creator A5063411006 @default.
• W2078709072 creator A5066993165 @default.
• W2078709072 creator A5073466449 @default.
• W2078709072 creator A5078366847 @default.
• W2078709072 creator A5090256464 @default.
• W2078709072 date "2012-07-01" @default.
• W2078709072 modified "2023-10-18" @default.
• W2078709072 title "Phase II Study of Accelerated High-Dose Radiotherapy With Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: Radiation Therapy Oncology Group Protocol 0239" @default.
• W2078709072 cites W1885320430 @default.
• W2078709072 cites W1905406155 @default.
• W2078709072 cites W1920090590 @default.
• W2078709072 cites W1973510243 @default.
• W2078709072 cites W1984254136 @default.
• W2078709072 cites W1992291788 @default.
• W2078709072 cites W2047037517 @default.
• W2078709072 cites W2124353451 @default.
• W2078709072 cites W2139248078 @default.
• W2078709072 cites W2150713507 @default.
• W2078709072 cites W2150878803 @default.
• W2078709072 cites W2323020638 @default.
• W2078709072 cites W2341745217 @default.
• W2078709072 cites W4293241248 @default.
• W2078709072 doi "https://doi.org/10.1016/j.ijrobp.2012.01.075" @default.
• W2078709072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3377848" @default.
• W2078709072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22560543" @default.
• W2078709072 hasPublicationYear "2012" @default.
• W2078709072 type Work @default.
• W2078709072 sameAs 2078709072 @default.
• W2078709072 citedByCount "40" @default.
• W2078709072 countsByYear W20787090722013 @default.
• W2078709072 countsByYear W20787090722014 @default.
• W2078709072 countsByYear W20787090722015 @default.
• W2078709072 countsByYear W20787090722016 @default.
• W2078709072 countsByYear W20787090722017 @default.
• W2078709072 countsByYear W20787090722018 @default.
• W2078709072 countsByYear W20787090722019 @default.
• W2078709072 countsByYear W20787090722020 @default.
• W2078709072 countsByYear W20787090722021 @default.
• W2078709072 countsByYear W20787090722022 @default.
• W2078709072 countsByYear W20787090722023 @default.
• W2078709072 crossrefType "journal-article" @default.
• W2078709072 hasAuthorship W2078709072A5011307937 @default.
• W2078709072 hasAuthorship W2078709072A5019357584 @default.
• W2078709072 hasAuthorship W2078709072A5026088869 @default.
• W2078709072 hasAuthorship W2078709072A5032192226 @default.
• W2078709072 hasAuthorship W2078709072A5060222943 @default.
• W2078709072 hasAuthorship W2078709072A5063411006 @default.
• W2078709072 hasAuthorship W2078709072A5066993165 @default.
• W2078709072 hasAuthorship W2078709072A5073466449 @default.
• W2078709072 hasAuthorship W2078709072A5078366847 @default.
• W2078709072 hasAuthorship W2078709072A5090256464 @default.
• W2078709072 hasBestOaLocation W20787090722 @default.
• W2078709072 hasConcept C126322002 @default.
• W2078709072 hasConcept C141071460 @default.
• W2078709072 hasConcept C143998085 @default.
• W2078709072 hasConcept C2776256026 @default.
• W2078709072 hasConcept C2776694085 @default.
• W2078709072 hasConcept C2776907518 @default.
• W2078709072 hasConcept C2778119113 @default.
• W2078709072 hasConcept C2778239845 @default.
• W2078709072 hasConcept C2778822529 @default.
• W2078709072 hasConcept C2779134260 @default.
• W2078709072 hasConcept C2779562246 @default.
• W2078709072 hasConcept C2779920096 @default.
• W2078709072 hasConcept C43270747 @default.
• W2078709072 hasConcept C45393284 @default.
• W2078709072 hasConcept C500558357 @default.
• W2078709072 hasConcept C509974204 @default.
• W2078709072 hasConcept C71924100 @default.
• W2078709072 hasConcept C90924648 @default.
• W2078709072 hasConceptScore W2078709072C126322002 @default.
• W2078709072 hasConceptScore W2078709072C141071460 @default.
• W2078709072 hasConceptScore W2078709072C143998085 @default.
• W2078709072 hasConceptScore W2078709072C2776256026 @default.
• W2078709072 hasConceptScore W2078709072C2776694085 @default.
• W2078709072 hasConceptScore W2078709072C2776907518 @default.
• W2078709072 hasConceptScore W2078709072C2778119113 @default.
• W2078709072 hasConceptScore W2078709072C2778239845 @default.
• W2078709072 hasConceptScore W2078709072C2778822529 @default.
• W2078709072 hasConceptScore W2078709072C2779134260 @default.
• W2078709072 hasConceptScore W2078709072C2779562246 @default.
• W2078709072 hasConceptScore W2078709072C2779920096 @default.
• W2078709072 hasConceptScore W2078709072C43270747 @default.
• W2078709072 hasConceptScore W2078709072C45393284 @default.
• W2078709072 hasConceptScore W2078709072C500558357 @default.
• W2078709072 hasConceptScore W2078709072C509974204 @default.
• W2078709072 hasConceptScore W2078709072C71924100 @default.
• W2078709072 hasConceptScore W2078709072C90924648 @default.
• W2078709072 hasIssue "4" @default.
• W2078709072 hasLocation W20787090721 @default.
• W2078709072 hasLocation W20787090722 @default.

• next